WS #13409
Novo Nordisk hikes outlook but shares fall 5% as guidance disappoints; Q2 sales up 3% cc.
Novo Nordisk guidance disappoints
Novo Nordisk hikes outlook but shares fall 5% as guidance disappoints; Q2 sales up 3% cc.
Novo Nordisk hikes outlook but shares fall 5% as guidance disappoints; Q2 sales up 3% cc.
Novo Nordisk hikes outlook but shares fall 5% as guidance disappoints; Q2 sales up 3% cc.